Opendata, web and dolomites
THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (Belgium): list of projects
The following table shows the list of Horizon 2020 projects developed by "THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | N2B-patch | H2020-EU.2.1.3. | participant | 127˙292.00 | 2017-01-01 | 1108 |
| 2 | DO-IT | H2020-EU.3.1.7. | participant | 120˙745.00 | 2017-02-01 | 988 |
| totale | 248˙037.00 | |||||
Network analysis
This organization collaborated with partners in 14 countries.
N2B-patch
Within the project N2B-patch this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | CH | NovaGo | NOVAGO THERAPEUTICS AG (PRC) |
| participant | DE | Bei | BEITER GMBH GO KG (PRC) |
| participant | UK | Jen | JENSONR+ LIMITED (PRC) |
| participant | DE | HBC | HOCHSCHULE BIBERACH (HES) |
| participant | CZ | CNT | CONTIPRO AS (PRC) |
| participant | DE | JET | MJR PHARMJET GMBH (PRC) |
| participant | EL | CERTH-HIT | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
| participant | IT | LENS | LABORATORIO EUROPEO DI SPETTROSCOPIE NON LINEARI (REC) |
| participant | FR | LGI | LGI CONSULTING (PRC) |
| participant | CH | UBERN | UNIVERSITAET BERN (HES) |
| coordinator | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
DO-IT
Within the project DO-IT this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
| participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
| participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
| participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
| participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
| participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
| participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
| participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | BE | Amgen | AMGEN (PRC) |
| participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
| participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
| participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
| coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo | NOVO NORDISK A/S (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
| participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
| participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |